[HTML][HTML] Diagnostic, prognostic, and therapeutic roles of gut microbiota in COVID-19: a comprehensive systematic review
Introduction The Coronavirus Disease 2019 (COVID-19) pandemic caused by Severe Acute
Respiratory Coronavirus 2 (SARS-CoV-2) emerged in late December 2019. Considering the …
Respiratory Coronavirus 2 (SARS-CoV-2) emerged in late December 2019. Considering the …
Fungal infection in co-infected patients with COVID-19: an overview of case reports/case series and systematic review
SS Seyedjavadi, P Bagheri, MJ Nasiri… - Frontiers in …, 2022 - frontiersin.org
Fungal co-infections are frequent in patients with coronavirus disease 2019 (COVID-19) and
can affect patient outcomes and hamper therapeutic efforts. Nonetheless, few studies have …
can affect patient outcomes and hamper therapeutic efforts. Nonetheless, few studies have …
Gut microbiota and COVID-19: potential implications for disease severity
G Rocchi, M Giovanetti, F Benedetti, A Borsetti… - Pathogens, 2022 - mdpi.com
The SARS-CoV-2 pandemic resulted in an unprecedented global crisis. SARS-CoV-2
primarily causes lung infection trough the binding of the virus with the ACE-2 cell receptor …
primarily causes lung infection trough the binding of the virus with the ACE-2 cell receptor …
Identification of robust protein associations with COVID-19 disease based on five clinical studies
K Suhre, H Sarwath, R Engelke, MU Sohail… - Frontiers in …, 2022 - frontiersin.org
Multiple studies have investigated the role of blood circulating proteins in COVID-19 disease
using the Olink affinity proteomics platform. However, study inclusion criteria and sample …
using the Olink affinity proteomics platform. However, study inclusion criteria and sample …
Increased abundance of Achromobacter xylosoxidans and Bacillus cereus in upper airway transcriptionally active microbiome of COVID-19 mortality patients indicates …
The modulators of severe COVID-19 have emerged as the most intriguing features of SARS-
CoV-2 pathogenesis. This is especially true as we are encountering variants of concern …
CoV-2 pathogenesis. This is especially true as we are encountering variants of concern …
[HTML][HTML] Factors modulating COVID-19: A mechanistic understanding based on the adverse outcome pathway framework
Addressing factors modulating COVID-19 is crucial since abundant clinical evidence shows
that outcomes are markedly heterogeneous between patients. This requires identifying the …
that outcomes are markedly heterogeneous between patients. This requires identifying the …
COVID-19 vaccine platforms: challenges and safety contemplations
HT Al-Jighefee, H Najjar, MN Ahmed, A Qush… - Vaccines, 2021 - mdpi.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a
pandemic as of March 2020, creating a global crisis and claiming millions of lives. To halt …
pandemic as of March 2020, creating a global crisis and claiming millions of lives. To halt …
An insight to the therapeutic potential of algae-derived sulfated polysaccharides and polyunsaturated fatty acids: Focusing on the COVID-19
Covid-19 pandemic severely affected human health worldwide. The rapidly increasing
COVID-19 cases and successive mutations of the virus have made it a major challenge for …
COVID-19 cases and successive mutations of the virus have made it a major challenge for …
Toxin-like peptides from the bacterial cultures derived from gut microbiome infected by SARS-CoV-2—new data for a possible role in the long COVID pattern
C Brogna, S Cristoni, B Brogna, DR Bisaccia, G Marino… - Biomedicines, 2022 - mdpi.com
It has been 3 years since the beginning of the SARS-CoV-2 outbreak, however it is as yet
little known how to care for the acute COVID-19 and long COVID patients. COVID-19 clinical …
little known how to care for the acute COVID-19 and long COVID patients. COVID-19 clinical …
The role of pathogens in diabetes pathogenesis and the potential of immunoproteomics as a diagnostic and prognostic tool
MU Sohail, F Mashood, A Oberbach… - Frontiers in …, 2022 - frontiersin.org
Diabetes mellitus (DM) is a group of metabolic diseases marked by hyperglycemia, which
increases the risk of systemic infections. DM patients are at greater risk of hospitalization …
increases the risk of systemic infections. DM patients are at greater risk of hospitalization …